Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neoplasms and tor[original query] |
---|
PTX3 genetic variation and dizygotic twinning in the Gambia: could pleiotropy with innate immunity explain common dizygotic twinning in Africa? Annals of human genetics 2012 Jul . Sirugo G, Edwards DR, Ryckman KK, Bisseye C, White MJ, Kebbeh B, Morris GA, Adegbola RA, Tacconelli A, Predazzi IM, Novelli G, Vannberg FO, Odunsi K, Page GP, Williams SM |
Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics. Drug metabolism and disposition: the biological fate of chemicals 2012 Jun 40 (6): 1210-5. Edavana Vineetha Koroth, Dhakal Ishwori B, Yu Xinfeng, Williams Suzanne, Kadlubar Sus |
Tumor-biopsy stratification based on mTOR-pathway activity and functional mutations in the upstream genes PIK3CA and PTEN. Oncotarget 2017 Oct 8 (48): 84426-84433. Laes Jean-François, Sauvage Sebastien, Ghitti Grego |
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China. International journal of cancer 2018 Jul . Lan Bo, Ma Fei, Chen Shanshan, Wang Wenna, Li Qiao, Fan Ying, Luo Yang, Cai Ruigang, Wang Jiayu, Yuan Peng, Zhang Pin, Li Qing, Xu Bing |
Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients. The pharmacogenomics journal 2020 Feb . Bonnet Stéphanie, Falkowski Sabrina, Deppenweiler Marine, Monchaud Caroline, Arnion Hélène, Picard Nicolas, Woillard Jean-Baptis |
Comparison of adverse drug reactions between tamoxifen and toremifene in breast cancer patients with different CYP2D6 genotypes: A propensity-score matched cohort study. International journal of cancer 2021 12 150 (10): 1664-1676. Zhou Weihang, Jiang Yiwei, Xu Yaqian, Wang Yaohui, Ma Xiaowei, Zhou Liheng, Lin Yanping, Wang Yan, Wu Ziping, Li Min, Yin Wenjin, Lu Jinso |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: